Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.79 |
| ▸ | TSHR | P16473 | 4/20 | 0.79 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.79 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.33 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclohexane SCHEMBL346356 | 1.00 | ALDH1A1 (0.79) | ALDH1A1TSHRFGFR4LMNATDP1 | |
| Acrylamide SCHEMBL1332245 | 0.89 | — | — | |
| Acrylamide SCHEMBL170034 | 0.89 | TSHR (1.00) | ALDH1A1TSHRFGFR4LMNATDP1 | |
| Acrylamide SCHEMBL1332254 | 0.89 | — | — | |
| Acrylamide SCHEMBL3051 | 0.89 | — | — | |
| Acrylamide SCHEMBL183292 | 0.89 | TSHR (1.00) | ALDH1A1TSHRFGFR4LMNATDP1 | |
| Acrylamide SCHEMBL8940372 | 0.85 | ALDH1A1 (0.92) | ALDH1A1TSHRFGFR4LMNATDP1 | |
| Acrylamide SCHEMBL20701874 | 0.85 | — | — | |
| Acrylamide SCHEMBL9848722 | 0.85 | ALDH1A1 (0.92) | ALDH1A1TSHRFGFR4LMNATDP1 | |
| Acrylamide SCHEMBL22412946 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108289828-A | Polyacrylate, preparation method and use its application | 莫门蒂夫性能材料股份有限公司 | 2018-07-17 | — | — | CN | disclosed |
| EP-1622575-B1 | STICK COMPOSITIONS | UNILEVER PLC (GB) | 2011-07-27 | — | — | EP | disclosed |
| US-7347991-B2 | combination of gelling agents comprising 1) Ax CO Rx where Ax is an amino acid amide residue, especially glutamic or aspartic acid and Rx is branched alkyl and 2) a different fiber-forming amido structurant; particularly for forming translucent deodorant or antiperspirant sticks | UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC. (US) | 2008-03-25 | — | — | US | disclosed |
| EP-1622575-A2 | STICK COMPOSITIONS | Unilever Plc (GB) | 2006-02-08 | — | — | EP | disclosed |
| WO-2004098553-A2 | STICK COMPOSITIONS | UNILEVER PLC (GB) | 2004-11-18 | — | — | WO | disclosed |
| US-20040223995-A1 | Stick compositions | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2004-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040223995-A1 | Stick compositions | QPCT, F12, ADM2 | ALDH1A1 1690/4885TSHR 1264/4885FGFR4 3607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.